IL15 and cancer: The mice immunized with 3 × 105 IL-15:IL-15Rα-B16F10-OVA or IL-15:IL-15Rα-CT26-OVA showed similar body weight changes to the no virus-infected cancer cells, indicating the tolerability of BV-based cancer cell immunization (Figure S3G,H).